Compare Mutual Funds
Pros | Among most bought funds within the category. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | - | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 2 Years 6 Months | 13 Years 5 Months | ||
Fund AUM | ₹2031 Cr | ₹8306 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.93% | 0.91% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 31 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.24% | 99.7% | ||
Debt % | - | - | ||
P/E | 44.86 | 35.73 | ||
P/B | 6.81 | 5.7 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -2.58% | -2.91% | ||
3-Month Return | 0.2% | -1.77% | ||
6-Month Return | 1.25% | -1.1% | ||
1-Year Return | 8.74% | 3.24% | ||
3-Year Return | - | 24.53% | ||
5-Year Return | - | 16.64% |
Sharpe | - | 1.17 | ||
Alpha | - | 0.22 | ||
Beta | - | 0.9 | ||
Standard Deviation | - | 15.21 | ||
Information Ratio | - | -0.47 |
Description | HDFC Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhruv Muchhal, Nikhil Mathur | Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma |
Most Popular Comparisons

